Saudi healthtech Metafare has raised $1 million to scale virtual reality wellness sessions powered by AI. The company is targeting both individual users and corporate clients with personalised fifteen-minute health experiences.
Saudi Arabia's healthcare system has a well-documented challenge with chronic conditions. Diabetes, cardiovascular disease, and obesity rates across the Kingdom are among the highest globally, and a predominantly reactive, facility-based care model has struggled to keep pace with the scale of the problem. Metafare, a Riyadh-based healthtech startup founded in 2025 by Ibrahim Almaghlouth, is taking a different approach entirely, one built around making wellness accessible, continuous, and genuinely easy to fit into daily life. The company has now closed its first funding round at $1 million, backed by Harmonics Ventures alongside a group of regional family offices.
The product Metafare is building combines virtual reality and artificial intelligence to deliver immersive wellness sessions that users can access remotely in fifteen minutes or less, from home or the workplace. Each session is personalised to the individual and spans a range of formats including fitness exercises, guided meditation, and cognitive behavioural therapy programs. The platform targets both individual consumers and corporate clients, recognising that the workplace is increasingly where preventive health and mental wellness interventions need to land if they are going to reach people consistently rather than occasionally.
Since launching in 2025, Metafare has delivered over 3,000 immersive wellness experiences across diverse user groups and achieved a 95% user satisfaction rate. It has also established early partnerships with healthcare providers and corporate entities, which gives it a foundation that goes beyond consumer app adoption into institutional distribution. That distinction matters because corporate health programs offer recurring, contracted revenue in a way that individual subscriptions do not, and they create the kind of volume needed to prove a model before expanding geographically.
The $1 million raised will be directed at three areas: strengthening Metafare's AI personalisation engine, expanding its health content library, and deepening its presence in the Saudi market before moving into wider Gulf markets. The phased approach is deliberate. Building product-market fit and operational density in one market before expanding is a smarter play than spreading thin across multiple GCC countries simultaneously, particularly in healthcare where trust, local partnerships, and regulatory relationships take time to build properly.
The broader context in Saudi Arabia supports Metafare's timing. Saudi Arabia's wellness market is valued at $19.8 billion and growing, with wellness tourism alone expanding at an annual rate of 66%. Vision 2030 has made healthcare transformation a national priority, creating both regulatory momentum and institutional appetite for technology-enabled care models. The MENA healthcare market is projected to exceed $256 billion, with digital health consistently cited as a top investment priority by sovereign wealth funds and institutional investors across the Gulf. Healthtech companies that align with national transformation agendas and build for regional realities are finding more receptive investors and cleaner paths to institutional partnerships than they would have three years ago.
What Metafare is building sits at the junction of several trends that are reinforcing each other across the region: the push toward preventive care, growing corporate investment in employee wellbeing, increasing comfort with digital and remote health services, and a young population that has grown up expecting technology to meet them where they are rather than requiring them to show up somewhere. The fifteen-minute VR wellness session is not just a product feature. It is a deliberate answer to the most common barrier to consistent health engagement, which is time. Whether that answer scales beyond early adopters into mainstream use will be the real test of the next twelve months.
